diclofenac has been researched along with lubiprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Higurashi, T; Honda, Y; Iwasaki, A; Kato, T; Kessoku, T; Kurita, Y; Nakajima, A; Ogawa, Y; Ohkubo, H; Sato, T; Uchiyama, S; Usuda, H; Wada, K; Yamanaka, T | 1 |
1 review(s) available for diclofenac and lubiprostone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for diclofenac and lubiprostone
| Article | Year |
|---|---|
Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
Topics: Adult; Chloride Channel Agonists; Chromatography, High Pressure Liquid; Diclofenac; Drug Administration Schedule; Endotoxins; Healthy Volunteers; Humans; Intestinal Mucosa; Intestines; Irritable Bowel Syndrome; Lactulose; Lubiprostone; Male; Mannitol; Mass Spectrometry; Middle Aged; Permeability; Pilot Projects; Prospective Studies; Young Adult | 2017 |